Sasha Campbell

Jul 21, 2017

Startup Statera Environmental is Commercializing Passive Sampling Technology to Enhance the Risk Analysis Process

Dr. Damian Shea and his team at North Carolina State University have developed a new passive sampling technology that provides more accurate estimates of chronic exposure to hundreds of bioavailable chemicals…

Jul 17, 2017

Startup Locus Biosciences Secures $5m Convertible Note for CRISPR-Cas3 Antimicrobials

Research Triangle Park-based Locus Biosciences has secured a $5 million convertible note. Chinese technology giant Tencent Holdings Limited led the financing round, which also included the N.C. Biotechnology Center. One…

Jul 17, 2017

Bridging the Funding Gap from Research to Commercialization

Five promising North Carolina State University projects will receive support from the Chancellor’s Innovation Fund (CIF), which helps NC State researchers move their inventions into the marketplace. “NC State is…

Jun 21, 2017

NC State Startup 410 Medical Receives Funding From Newly Formed Triangle Venture Alliance (TVA)

Triangle Venture Alliance (TVA), a newly formed investment alliance among angel networks at North Carolina State University, Duke University, the University of North Carolina at Chapel Hill and NC Central…

Jun 19, 2017

N.C. State/UNC spinout company raises $5.8M for ‘smart’ insulin devices

Technology invented in a laboratory in the UNC-NC State Joint Biomedical Engineering Program could soon mean painless diabetes testing and insulin injections for the nearly 400 million people with diabetes…

Jun 9, 2017

NC State Jumps to No. 80 Worldwide for U.S. Patents

Taking research to market is something NC State does better than most. And the fifth-annual worldwide rankings from the National Academy of Inventors (NAI) and the Intellectual Property Owners Association…

Jun 8, 2017

NC State University Chancellor’s Innovation Fund is Mobilizing a Bridge Over the Digital Divide

More than two billion people worldwide who don’t have internet access often miss out on life-changing benefits of being connected, such as automated micro-lending for entrepreneurs, marketplace applications and information…

May 26, 2017

Child with Rare Cancer is First to Receive NC State Startup Biomarck Pharmaceuticals’ Drug

A new drug, discovered and developed in the Triangle, shows promise in treating cancer. It’s a story CBS North Carolina first reported on last year. At the time, the drug…

Apr 24, 2017

2017 Daugherty Endowment Challenge Winners Announced at Lulu eGames

The winners of the 2017 Lulu eGames have been announced. Over 350 people attended the Lulu eGames LIVE event on Thursday, April 20 to see who would walk away a…

Apr 24, 2017

Biomarck Pharmaceuticals Gains FDA Allowance to Begin Human Trials for Inhaled Treatment for Adults with Lung Cancer

North Carolina based Biomarck Pharmaceuticals, Inc. has received FDA allowance l to begin human trials for their patented compound BIO-11006, for adults with lung cancer.  Discovered by Dr. Ken Adler…